Repro Med Systems Inc (REPR) financial statements (2021 and earlier)

Company profile

Business Address 24 CARPENTER RD
CHESTER, NY 10918
State of Incorp. NY
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments27,31532,43438,1297,4285,8715,1293,807
Cash and cash equivalents27,31532,43438,1297,4285,8715,1293,807
Receivables2,5733,7372,9663,4203,2353,5473,293
Inventory, net of allowances, customer advances and progress billings6,8305,6333,6673,0892,3882,7392,572
Inventory6,8305,6333,6673,0892,3882,7392,572
Prepaid expense808844543543387453257
Total current assets:37,52642,64845,30614,48011,88111,8679,929
Noncurrent Assets
Operating lease, right-of-use asset237272306340374407440
Property, plant and equipment1,1681,261818639612637616
Intangible assets, net (including goodwill)844885927873807786747
Intangible assets, net (excluding goodwill)844885927873807786747
Deferred income tax assets125350     
Other noncurrent assets20202020202020
Other undisclosed noncurrent assets  334251188  
Total noncurrent assets:2,3932,7862,4042,1232,0011,8501,822
TOTAL ASSETS:39,91945,43447,71116,60313,88213,71711,751
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,5225,2184,6532,6252,2642,1651,737
Accounts payable6251,3639201,097573875530
Accrued liabilities2,6103,0522,6868881,2971,1791,035
Employee-related liabilities287440524230190111172
Taxes payable 363523410205  
Debt333,5031,504142139138
Other undisclosed current liabilities141140140139   
Total current liabilities:3,6665,3618,2964,2682,4062,3041,875
Noncurrent Liabilities
Long-term debt and lease obligation96132168203239272306
Finance lease, liability 0123  
Operating lease, liability96131166202237272306
Other undisclosed noncurrent liabilities(96)(131)(166)(202) 13365
Total noncurrent liabilities: 132168203239405371
Total liabilities:3,7625,4938,4634,4712,6462,7082,246
Stockholders' equity
Stockholders' equity attributable to parent36,15739,94139,24712,13211,23611,0099,505
Common stock467467466424422422411
Treasury stock, value(3,844)(344)(344)(344)(344)(344)(344)
Additional paid in capital35,88135,33134,8876,7386,2935,9865,145
Retained earnings3,6534,4874,2385,3144,8654,9454,293
Total stockholders' equity:36,15739,94139,24712,13211,23611,0099,505
TOTAL LIABILITIES AND EQUITY:39,91945,43447,71116,60313,88213,71711,751

Income statement (P&L) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues4,0576,0807,7096,3306,2226,6175,349
Cost of revenue
(Cost of Goods and Services Sold)
(1,760)(2,140)(2,799)(2,542)(2,275)(2,234)(1,873)
Gross profit:2,2973,9414,9103,7883,9474,3833,476
Operating expenses(3,462)(3,582)(5,942)(3,205)(4,107)(3,558)(3,440)
Operating income (loss):(1,164)359(1,032)583(160)82436
Nonoperating income (expense)3134(13)9(26)1467
Foreign currency transaction gain (loss), before tax132(3)(10) (9)(1)
Other nonoperating income (expense)1910(5)19 2318
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes00004800
Income (loss) from continuing operations before income taxes:(1,133)393(1,045)591(137)838103
Income tax expense (benefit)298(143)(31)(142)57(187)(25)
Net income (loss) available to common stockholders, diluted:(835)249(1,076)449(80)65278

Comprehensive Income ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):(835)249(1,076)449(80)65278
Comprehensive income (loss), net of tax, attributable to parent:(835)249(1,076)449(80)65278

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: